GPR162 and Alzheimer disease: Cross-validation with an independent cohort confirmed that the combination of the ratio and the corresponding size of distribution mode of GABRD+- or GPR162+- carrying pTau217 EVs, and age can accurately discriminate between AD vs HC (AUC = 0.93), as well as AD vs NAD (AUC = 0.90).